These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38314829)

  • 1. Cultivating Ex Vivo Patient-Derived Glioma Organoids Using a Tissue Chopper.
    Alsalkini M; Cibulková V; Breun M; Kessler AF; Schulz T; Cattaneo A; Wipplinger C; Hübner J; Ernestus RI; Nerreter T; Monoranu CM; Hagemann C; Löhr M; Nickl V
    J Vis Exp; 2024 Jan; (203):. PubMed ID: 38314829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of glioblastoma organoids and their applications in personalized therapy.
    Xu C; Yuan X; Hou P; Li Z; Wang C; Fang C; Tan Y
    Cancer Biol Med; 2023 Jun; 20(5):353-68. PubMed ID: 37283493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Patient-Derived Glioblastoma with Cerebral Organoids.
    Linkous A; Balamatsias D; Snuderl M; Edwards L; Miyaguchi K; Milner T; Reich B; Cohen-Gould L; Storaska A; Nakayama Y; Schenkein E; Singhania R; Cirigliano S; Magdeldin T; Lin Y; Nanjangud G; Chadalavada K; Pisapia D; Liston C; Fine HA
    Cell Rep; 2019 Mar; 26(12):3203-3211.e5. PubMed ID: 30893594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of patient-derived organoid models of lower-grade glioma.
    Abdullah KG; Bird CE; Buehler JD; Gattie LC; Savani MR; Sternisha AC; Xiao Y; Levitt MM; Hicks WH; Li W; Ramirez DMO; Patel T; Garzon-Muvdi T; Barnett S; Zhang G; Ashley DM; Hatanpaa KJ; Richardson TE; McBrayer SK
    Neuro Oncol; 2022 Apr; 24(4):612-623. PubMed ID: 34850183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol.
    Toh TB; Thng DKH; Bolem N; Vellayappan BA; Tan BWQ; Shen Y; Soon SY; Ang YLE; Dinesh N; Teo K; Nga VDW; Low SW; Khong PL; Chow EK; Ho D; Yeo TT; Wong ALA
    PLoS One; 2024; 19(7):e0307818. PubMed ID: 39058662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
    Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
    Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma.
    Vizcaino MA; Palsgrove DN; Yuan M; Giannini C; Cabrera-Aldana EE; Pallavajjala A; Burger PC; Rodriguez FJ
    Brain Pathol; 2019 Mar; 29(2):193-204. PubMed ID: 30222900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Surgical and Colonoscopy Tissue to Establish Colorectal Patient-derived Organoids.
    Chen H; Yang Y; Shi J; Yan T; Wang J; Yang Y; Lu Q; Feng H; Du J; Cao Z; Weygant N
    Curr Cancer Drug Targets; 2024; 24(5):546-555. PubMed ID: 37997804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-phenotyping of IDH-mutant grade 3 astrocytoma and IDH-wildtype glioblastoma reveals specific differences in cells of myeloid origin.
    Raghavan JV; Ganesh RA; Sonpatki P; Naik D; John AE; Arunachalam P; Shah D; P S H; Lakshmikantha A; Pillai S; Chandrachari KP; Mariswamappa K; Lale S; Shah N; Jhunjhunwala S
    Oncoimmunology; 2021; 10(1):1957215. PubMed ID: 34377594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the Prognosis of High-Grade gliomas in the View of New Immunohistochemistry Markers and 2016 WHO Classification.
    Dolen D; Ahmadov T; Dolas I; Unal TC; Aydoseli A; Ozturk M; Sabanci PA; Aras Y; Bilgic MB; Sencer A
    Turk Neurosurg; 2022; 32(3):500-507. PubMed ID: 35615769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics.
    Krieger TG; Tirier SM; Park J; Jechow K; Eisemann T; Peterziel H; Angel P; Eils R; Conrad C
    Neuro Oncol; 2020 Aug; 22(8):1138-1149. PubMed ID: 32297954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer.
    Urbaniak A; Reed MR; Heflin B; Gaydos J; Piña-Oviedo S; Jędrzejczyk M; Klejborowska G; Stępczyńska N; Chambers TC; Tackett AJ; Rodriguez A; Huczyński A; Eoff RL; MacNicol AM
    Biomed Pharmacother; 2022 Sep; 153():113440. PubMed ID: 36076555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDH1
    Han X; Zhou H; Sun W; Hou L; Wang Y; Wang H; Lv Z; Xue X
    Sci Rep; 2023 Nov; 13(1):19659. PubMed ID: 37952042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A map of the spatial distribution and tumour-associated macrophage states in glioblastoma and grade 4 IDH-mutant astrocytoma.
    Yin W; Ping YF; Li F; Lv SQ; Zhang XN; Li XG; Guo Y; Liu Q; Li TR; Yang LQ; Yang KD; Liu YQ; Luo CH; Luo T; Wang WY; Mao M; Luo M; He ZC; Cao MF; Chen C; Miao JY; Zeng H; Wang C; Zhou L; Yang Y; Yang X; Wang QH; Feng H; Shi Y; Bian XW
    J Pathol; 2022 Oct; 258(2):121-135. PubMed ID: 35723032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 expression in higher-grade human glioma: a clinical and experimental study.
    Fels C; Schäfer C; Hüppe B; Bahn H; Heidecke V; Kramm CM; Lautenschläger C; Rainov NG
    J Neurooncol; 2000 Jul; 48(3):207-16. PubMed ID: 11100818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening.
    Zhang L; Liu F; Weygant N; Zhang J; Hu P; Qin Z; Yang J; Cheng Q; Fan F; Zeng Y; Tang Y; Li Y; Tang A; He F; Peng J; Liao W; Hu Z; Li M; Liu Z
    Cancer Lett; 2021 Mar; 500():87-97. PubMed ID: 33309780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous Glioblastoma Spheroid Infiltration of Early-Stage Cerebral Organoids Models Brain Tumor Invasion.
    da Silva B; Mathew RK; Polson ES; Williams J; Wurdak H
    SLAS Discov; 2018 Sep; 23(8):862-868. PubMed ID: 29543559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma.
    Nickl V; Eck J; Goedert N; Hübner J; Nerreter T; Hagemann C; Ernestus RI; Schulz T; Nickl RC; Keßler AF; Löhr M; Rosenwald A; Breun M; Monoranu CM
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine Response.
    Merrill NM; Kaffenberger SD; Bao L; Vandecan N; Goo L; Apfel A; Cheng X; Qin Z; Liu CJ; Bankhead A; Wang Y; Kathawate V; Tudrick L; Serhan HA; Farah Z; Ellimoottil C; Hafez KS; Herrel LA; Montgomery JS; Morgan TM; Salami SS; Weizer AZ; Ulintz PJ; Day ML; Soellner MB; Palmbos PL; Merajver SD; Udager AM
    Eur Urol; 2024 Nov; 86(5):434-444. PubMed ID: 39155193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.